Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Q3 2025 Earnings Call Transcript November 4, 2025
Day One Biopharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.19, expectations were $-0.27839.
Operator: Hello, ladies and gentlemen, and welcome to Day One Biopharmaceuticals Third Quarter 2025 Financial and Operating Results Conference Call. [Operator Instructions] Please be advised that this conference call is being recorded. I would now like to turn the call over to your...
